Zenas BioPharma, Inc. Effective Income Tax Rate Reconciliation Cross Border Tax Effect Amount
Zenas BioPharma, Inc. (ZBIO) reported Effective Income Tax Rate Reconciliation Cross Border Tax Effect Amount of $2.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount · last filed 2026-03-16
- Zenas BioPharma, Inc. effective income tax rate reconciliation cross border tax effect amount for fiscal 2025 was $2.25M.
| Period end | Effective Income Tax Rate Reconciliation Cross Border Tax Effect Amount 12 month |
|---|---|
| 2025-12-31 | $2.25M 10-K · filed 2026-03-16 |